Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term therapeutic use. Found 398 abstracts

no pagination
Kedziera PL. Easing elders' pain. Holist Nurs Pract. 2001 Jan;15(2):4-16.
Langer CJ. The emerging world role of irinotecan in lung cancer. Oncology (Huntingt). 2001 Jul;15(7 Suppl 8):15-21.
Langer CJ. The role of UFT and the combination of UFT/leucovorin in non-small cell lung cancer. Lung Cancer. 2001 Nov;34(2):297-303.
Langer CJ. Staging and prognosis in lung cancer: making the complex accessible. Cancer Treat Res. 2001 Jan;105:53-94.
Langer CJ. Treatment of non-small-cell lung cancer in North America: the emerging role of irinotecan. Oncology (Huntingt). 2001 Jan;15(1 Suppl 1):19-24.
Langer CJ, Hoffman JP, Ottery FD. Clinical significance of weight loss in cancer patients: rationale for the use of anabolic agents in the treatment of cancer-related cachexia. Nutrition. 2001 Jan;17(1 Suppl):S1-20.
Meropol NJ, Niedzwiecki D, Hollis D, Schilsky RL, Mayer RJ. Phase II study of oral eniluracil, 5-fluorouracil, and leucovorin in patients with advanced colorectal carcinoma. Cancer. 2001 Apr;91(7):1256-63.
Murphy BA, Leong T, Burkey B, Langer C, Forastiere A. Lack of efficacy of topotecan in the treatment of metastatic or recurrent squamous carcinoma of the head and neck: an Eastern Cooperative Oncology Group Trial (E3393). Am J Clin Oncol. 2001 Feb;24(1):64-6.
Obasaju C, Hudes GR. Paclitaxel and docetaxel in prostate cancer. Hematol Oncol Clin North Am. 2001 Jun;15(3):525-45.
Obasaju C, Manola J, Hudes GR, Khandekar JD, Citrin DL, Carbone P, Trump DL. Phase II evaluation of menogaril in advanced prostate cancer: Eastern Cooperative Oncology Group EST P-A885. Am J Clin Oncol. 2001 Apr;24(2):150-4.
Ozols RF. The current role of gemcitabine in ovarian cancer. Semin Oncol. 2001 Apr;28(2 Suppl 7):18-24.
Pandya KJ, Yeap BY, Weiner LM, Krook JE, Erban JK, Schinella RA, Davis TE. Megestrol and tamoxifen in patients with advanced endometrial cancer: an Eastern Cooperative Oncology Group Study (E4882). Am J Clin Oncol. 2001 Feb;24(1):43-6.
Pingpank JF, Hoffman JP, Ross EA, Cooper HS, Meropol NJ, Freedman G, Pinover WH, LeVoyer TE, Sasson AR, Eisenberg BL. Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas. J Gastrointest Surg. 2001 Mar;5(2):121-30.
Rothenberg ML, Meropol NJ, Poplin EA, Van Cutsem E, Wadler S. Mortality associated with irinotecan plus bolus fluorouracil/leucovorin: summary findings of an independent panel. J Clin Oncol. 2001 Sep 15;19(18):3801-7.
Runnebaum IB, Wang-Gohrke S, Vesprini D, Kreienberg R, Lynch H, Moslehi R, Ghadirian P, Weber B, Godwin AK, Risch H, Garber J, Lerman C, Olopade OI, Foulkes WD, Karlan B, Warner E, Rosen B, Rebbeck T, Tonin P, Dube MP, Kieback DG, Narod SA. Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives. Pharmacogenetics. 2001 Oct;11(7):635-8.
Sasson AR, Hoffman JP, Ross E, Meropol NJ, Szarka CE, Freedman G, Pinover W, Pingpank JF, Eisenberg BL. Trimodality therapy for advanced gallbladder cancer. Am Surg. 2001 Mar;67(3):277-83; discussion 284.
Sasson AR, Watson JC, Sigurdson ER. Hepatic artery infusional chemotherapy for colorectal liver metastases. Cancer Treat Res. 2001 Jan;109:279-98.
Schilder RJ, Gallo JM, Millenson MM, Bookman MA, Weiner LM, Rogatko A, Rogers B, Padavic-Shallers K, Boente M, Rosenblum N, Adams AL, Ciccotto S, Ozols RF. Phase I trial of multiple cycles of high-dose carboplatin, paclitaxel, and topotecan with peripheral-blood stem-cell support as front-line therapy. J Clin Oncol. 2001 Feb 15;19(4):1183-94.
Segal DM, Weiner GJ, Weiner LM. Introduction: bispecific antibodies. J Immunol Methods. 2001 Feb;248(1-2):1-6.
Smith MR, Xie T, Zhou ZZ, Joshi I. Efficacy of treatment with antisense oligonucleotides complementary to immunoglobulin sequences of bcl-2/immunoglobulin fusion transcript in a t(14;18) human lymphoma-scid mouse model. Clin Cancer Res. 2001 Feb;7(2):400-6.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term therapeutic use

therapeutic use Human drug therapy Antineoplastic Combined Chemotherapy Protocols Female administration & dosage Male Middle Age Aged Survival Analysis pathology US Gov't Support-PHS therapy mortality Adult genetics Antineoplastic Agents Non-US Gov't Support 80 and over Aged Adjuvant Chemotherapy adverse effects Lung Neoplasms Treatment Outcome Prognosis Adjuvant Radiotherapy Clinical Trials Adenocarcinoma Local Neoplasm Recurrence Fluorouracil analogs & derivatives adverse effects Neoplasm Metastasis Paclitaxel methods Drug Administration Schedule Leucovorin United States Non-Small-Cell Lung Carcinoma Survival Rate Risk Factors pharmacology secondary derivatives Oral Administration Prostatic Neoplasms Randomized Controlled Trials Apoptosis immunology Colorectal Neoplasms Neoplasm Staging Animal Neoplasms radiotherapy Ovarian Neoplasms bcl-2 Genes Uracil Carboplatin Topotecan metabolism chemically induced complications Proportional Hazards Models Deoxycytidine Squamous Cell Carcinoma analogs & Neoplasm Proteins Enzyme Inhibitors Antineoplastic Antimetabolites Retrospective Studies Camptothecin antagonists & inhibitors Phytogenic Antineoplastic Agents Hydrocortisone Acute Disease Oxidoreductases Breast Neoplasms Appetite Stimulants Carcinoma Weight Loss use Hematopoietic Stem Cell Transplantation Liver Neoplasms Hospitalization Gastrointestinal Diseases dosage Safety Pain Proto-Oncogene Proteins c-bcl-2 Immunoglobulin Fragments Diagnostic Imaging Palliative Care Progesterone Receptors etiology Intra-Arterial Infusions Cholecystitis drug effects therapeutic Mitoxantrone Nutrition Disorders physiopathology Lung Japan Microtubules Practice Guidelines Nutritional Status Antineoplastic Antibiotics Gallbladder Neoplasms Body Weight Non-Small-Cell Carcinoma Cultured Tumor Cells Neoplasm Drug Resistance Drug Combinations Bispecific Antibodies Mortality Neutropenia Tegafur BRCA2 Genes Syndrome BRCA1 Genes diagnosis Physical Examination Quality of Life Anabolic Steroids Germ-Line Mutation Human Chromosomes-Pair 14 Genetic Predisposition to Disease Phase I Clinical Trials pharmacokinetics Drug Synergism Pancreaticoduodenectomy Pain Measurement Lymphatic Metastasis Telomerase Tubulin Signal Transduction Hormone-Dependent Neoplasms Etoposide Recurrence Endometrial Neoplasms Large Cell Carcinoma Mice Post-Translational Protein Processing Phase II Clinical Trials Fusion Oncogene Proteins Cause of Death Estramustine Time Factors Malignant Pleural Effusion Jaundice
Last updated on Wednesday, February 05, 2020